Credit Suisse Maintains Outperform on 1Life Healthcare, Lowers Price Target to $32
Credit Suisse analyst Jailendra Singh maintains 1Life Healthcare (NASDAQ:ONEM) with a Outperform and lowers the price target from $39 to $32.
Cathie Wood’s ARK Invest Posts Fund Purchases For Monday, Dec. 13, 2021: SYSS, NTLA, DNA, PD, BLI, CRSP, MTLS, NVTA, VUZI, BLDE, ROKU, COIN, EDR, ONEM, SDGR, ACCD, SLGC, MASS, QSI, PSNL, PATH, TOST, HOOD, SE, NU, KTOS, AVAV
STRATASYS LTD (SSYS) - 78600
INTELLIA THERAPEUTICS INC (NTLA) - 16800
GINKGO BIOWORKS HOLDINGS INC (DNA) - 130745
PAGERDUTY INC (PD) - 24394
BERKELEY LIGHTS INC (BLI) - 29549
CRISPR THERAPEUTICS AG (CRSP) -
Cathie Wood’s ARK Invest Posts Fund Purchases For Monday, Nov. 15, 2021: NTLA, TWOU, VCYT, BEAM, MTLS, PRLB, TSP, ACHR, VLD, SPLK, DIS, BFLY, SGFY, ONEM, ALLO, VERV, QSI, HOOD, DKNG, TWLO, TOST, PAG, GRMN, DDD, MKFG
Intellia Therapeutics (NTLA)
2U (TWOU)
Veracyte (VCYT)
Beam Therapeutics (BEAM)
Materialise (MTLS)
Proto Labs (PRLB)
TuSimple Holdings (TSP)
Archer Aviation (ACHR)
Velo3d (VLD)
Splunk (SPLK)
The Walt Disney
SVB Leerink Maintains Market Perform on 1Life Healthcare, Raises Price Target to $24
SVB Leerink analyst Whit Mayo maintains 1Life Healthcare (NASDAQ:ONEM) with a Market Perform and raises the price target from $22 to $24.
Keybanc Maintains Overweight on 1Life Healthcare, Lowers Price Target to $30
Keybanc analyst Donald Hooker maintains 1Life Healthcare (NASDAQ:ONEM) with a Overweight and lowers the price target from $38 to $30.
1Life Healthcare Q3 EPS $(0.51) Misses $(0.25) Estimate, Sales $151.33M Beat $125.72M Estimate
1Life Healthcare (NASDAQ:ONEM) reported quarterly losses of $(0.51) per share which missed the analyst consensus estimate of $(0.25) by 104 percent. This is a 292.31 percent decrease over losses of $(0.13) per share from
Earnings Scheduled For November 3, 2021
Companies Reporting Before The Bell
• R.R.Donnelley & Sons (NYSE:RRD) is likely to report quarterly earnings at $0.32 per share on revenue of $1.19 billion.
Analyst Ratings For 1Life Healthcare
Over the past 3 months, 5 analysts have published their opinion on 1Life Healthcare (NASDAQ:ONEM) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.
SVB Leerink Initiates Coverage On 1Life Healthcare with Market Perform Rating, Announces Price Target of $22
SVB Leerink analyst Whit Mayo initiates coverage on 1Life Healthcare (NASDAQ:ONEM) with a Market Perform rating and announces Price Target of $22.
Cathie Wood’s ARK Invest Posts Fund Purchases For Monday, Sept. 13, 2021: NVTA, SGFY, PD, VCYT, MKFG, COIN, ZM, HOOD, KVSB, DIS, CND, ONEM, BLI, SLGC, PSNL, CRSP, WDAY
Invitae (NVTA) - 480,982
Signify Health (SGFY) - 250,366
PagerDuty (PD) - 152,577
Veracyte (VCYT) - 75,815
Markforged Holding Corp (MKFG) - 96,888
Coinbase